Blood DNA methylation machine learning signatures classified brain insulin resistance across three cohorts
A machine-learning framework applied to blood DNA-methylation profiles identified 540 CpG sites that classified brain insulin resistance in adults without type 2 diabetes. In the 167-person discovery cohort, the selected methylation signature was tested in two separate replication cohorts of 33 and 24 participants, with reported classification accuracy of 83–94%. The CpGs mapped to 445 genes enriched for neuronal-development and axonogenesis annotations; 98 sites showed significant blood–brain methylation correlation.
Technology: Supervised machine-learning framework using blood DNA-methylation profiles; a multi-fold elastic-net approach was described in the associated institutional and conference materials
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: In the 167-person discovery cohort, the selected methylation signature was tested in two separate replication cohorts of 33 and 24 participants, with reported classification accuracy of 83–94%.
- Still unknown: This is a biomarker-classification study, not a prospective clinical screening or intervention study. The discovery cohort had 167 participants and the replication cohorts were small (n=33 and n=24); replication accuracy is reported as 83–94%, and larger independent cohorts are needed to establish transportability. Blood–brain methylation correlations at 98 sites support a proxy relationship but do not show that peripheral methylation causes brain insulin resistance. The authors describe potential future diagnostic use rather than demonstrated clinical utility.
- AI role: The supervised model selected a 540-CpG methylation signature from peripheral blood measurements to classify participants with and without brain insulin resistance, and the signature was assessed in two replication cohorts. The model-derived CpG set was then used for differential-methylation, gene-annotation and blood–brain correlation analyses.
Evidence sources: https://pubmed.ncbi.nlm.nih.gov/40768600/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 47 of works of the same type, year and subfield (OpenAlex work metrics, 2 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.